|Slideshows|August 23, 2019

7 elements of pretest counseling

Author(s)Mary E. Norton, MD, Renée L. Chard, MSc, CGC

While most genetic disorders occur in patients with no relevant family history or risk factors, patients who have a family history of concern often benefit from genetic counseling.

While most genetic disorders occur in patients with no relevant family history or risk factors, patients who have a family history of concern often benefit from genetic counseling.Â For more information on genetic testing:Â New tools for counseling on prenatal genetic testing

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

November 6th, 2026

FAQ: Who is a candidate for testosterone therapy in women?

This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.

November 6th, 2026

FAQ: What does the evidence show about testosterone in women?

This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.

November 6th, 2026

Q&A: Kanchi Chadha, MD, FACOG, MSCP, on FDA boxed warning removals

Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.

November 6th, 2026

HRSA opens $1 million funding to update women's preventive guidelines

HRSA will award up to $1 million to a single organization to update the Women's Preventive Services Guidelines through the new WISH program.

November 6th, 2026

Maternal RSVpreF vaccine tied to fewer infant RSV hospitalizations

Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.

November 5th, 2026

Q&A: Soma Mandal, MD, MSCP, on FDA boxed warning removals for MHT

Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific rationale.

November 5th, 2026

Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule

CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not included in the final fee schedule for 2027, according to ACOG.